MEDS in America Act

To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to establish a competitive grant program under which the Secretary will award grants to certain institutions to establish American Biopharmaceutical Manufacturing Worker Training Centers of Excellence, and for other purposes. 1. Short title This Act may be cited as the Making Essential Drugs in America Act MEDS in America Act 2. American Biopharmaceutical Manufacturing Worker Training Centers of Excellence (a) In general The Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, shall establish a competitive grant program under which the Secretary will award not more than 20 grants to eligible institutions to establish centers of excellence with respect to recruitment and training of biopharmaceutical manufacturing workers in the United States, to be known as American Biopharmaceutical Manufacturing Worker Training Centers of Excellence Centers of Excellence (b) Grants (1) Amount The amount of a grant under subsection (a) shall not exceed $1,000,000 per year. (2) Duration The term of a grant under this section shall not exceed 5 years. (3) Application An eligible institution seeking a grant under this section shall submit to the Secretary an application at such time and in such manner as the Secretary may require that contains— (A) an outline of the institution’s plans to recruit and train workers who would be proficient in United States biopharmaceutical manufacturing, including continuous manufacturing, vaccine manufacturing, and working as sterile operators; and (B) such other information as the Secretary may require. (c) Eligible institution defined In this section, the term eligible institution 20 U.S.C. 1001 National Apprenticeship Act 29 U.S.C. 50 et seq. (d) Technical assistance The Secretary may provide technical assistance to an eligible institution seeking to establish a Center of Excellence, including technical assistance provided through an advisory committee of the Food and Drug Administration. (e) Report Not later than 2 years after the date on which the first grant is awarded under this section, the Comptroller General of the United States shall submit to Congress a report that— (1) assesses the effectiveness of the program established under this section; and (2) makes recommendations with respect to additional measures that may be needed to support worker training for biopharmaceutical manufacturing jobs in the United States. (f) Authorization of appropriations (1) In general There is authorized to be appropriated to carry out this section $100,000,000 for the period of fiscal years 2022 through 2026. (2) Reservation of funds for historically black colleges and universities and other minority-serving institutions Of the amounts made available under paragraph (1) for a fiscal year, the Secretary shall reserve not less than 20 percent for grants to institutions that are institutions of higher education eligible to receive funds under section 371(a) of the Higher Education Act of 1965 ( 20 U.S.C. 1067q(a)

Summary: Making Essential Drugs in America Act or the MEDS in America Act This bill requires the Food and Drug Administration to provide grants for institutions to establish centers for recruiting and training biopharmaceutical manufacturing workers. Eligible institutions include institutions of higher education and entities conducting registered apprenticeship programs.